Top Markets
Coin of the day
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Rank in Stocks #4908
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Share Price
$3.46
Last synced: 2026-08-26
Market Cap
$3.18B
Change (1 day)
-0.87%
Change (1 year)
-51.34%
Country
CN
Trade Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Category

Stock split history for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. stock (symbol: 300255) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 27, 2026.
One 300255 share bought prior to Aug 27, 2026 would equal to 0 300255 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH